Low levels of ventricular CSF orexin/hypocretin in advanced PD

Neurology

Volumn 61, Issue 4, 2003, Pages 540-543

  Drouot, Xavier ^a   Moutereau, S ^a   Nguyen, J P ^a   Lefaucheur, J P ^a   Creange A ^a   Remy, P ^a   Goldenberg, F ^a   d'Ortho, M P ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OREXIN;

ARTICLE; BRAIN VENTRICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MEASUREMENT; PARKINSON DISEASE; PRIORITY JOURNAL; SOMNOLENCE;

EID: 0042432035     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000078194.53210.48     Document Type: Article

References (10)

1. Daley JT, Turner RS, Bliwise DL, Rye DB. Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep 1999;22:S218-219.
2. Kilduff TS, Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 2000;23:359-365.
3. Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001;57:2253-2258.
4. Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK. Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 1999;260:161-164.
5. Langston JW, Forno LS. The hypothalamus in Parkinson disease. Ann Neurol 1978;3:129-133.
6. Overeem S, van Hilten JJ, Ripley B, Mignot E, Nishino S, Lammers GJ. Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness. Neurology 2002;58:498-499.
7. Kanbayashi T, Kawanishi K, Ishiguro H, et al. CSF hypocretin concentration in various neurological disorders and sleep apnea syndrome. Sleep 2002;25(suppl):A496. Abstract.
8. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999;14:922-927.
9. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002;58:1019-1024.
10. O'Suilleabhain PE, Dewey RB, Jr. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002;59:986-989.